Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | G6PD | P11413 | 2/20 | 0.36 |
| ▸ | TDP2 | O95551 | 4/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.34 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.34 |
| ▸ | RORC | P51449 | 1/20 | 0.32 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | RARG | P13631 | 1/20 | 0.31 |
| ▸ | MAT2A | P31153 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17464690 | 1.00 | KDM4E (0.43) | KDM4EATML3MBTL1G6PDTDP2 | |
| SCHEMBL17464785 | 0.95 | KDM4E (0.41) | KDM4EATML3MBTL1G6PDTDP2 | |
| SCHEMBL17463313 | 0.95 | KDM4E (0.41) | KDM4EATML3MBTL1G6PDTDP2 | |
| SCHEMBL17463240 | 0.95 | KDM4E (0.45) | KDM4EATML3MBTL1G6PDTDP2 | |
| SCHEMBL17463448 | 0.95 | KDM4E (0.45) | KDM4EATML3MBTL1G6PDTDP2 | |
| SCHEMBL17463245 | 0.95 | KDM4E (0.45) | KDM4EATML3MBTL1G6PDTDP2 | |
| SCHEMBL24988433 | 0.94 | KDM4E (0.41) | KDM4EATML3MBTL1G6PDTDP2 | |
| SCHEMBL22907605 | 0.94 | KDM4E (0.41) | KDM4EATML3MBTL1G6PDTDP2 | |
| SCHEMBL22907622 | 0.94 | KDM4E (0.41) | KDM4EATML3MBTL1G6PDTDP2 | |
| SCHEMBL24987658 | 0.94 | KDM4E (0.41) | KDM4EATML3MBTL1G6PDTDP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160028030-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2016-01-28 | — | — | US | disclosed |
| US-20160028030-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2016-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160028030-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNE2, CCNE1 | KDM4E 1882/4885ATM 1164/4885L3MBTL1 863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.